FullHope Biomedical Co.,Ltd. (TPEX:7773)
Taiwan · Delayed Price · Currency is TWD 26.75
-0.10 (-0.37%)
At close: Aug 3, 2026
FullHope Biomedical Market Cap
FullHope Biomedical has a market cap or net worth of 1.07 billion as of August 4, 2026. Its market cap has decreased by -25.38% in one year.
Market Cap
1.07B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
26.75
ChartMarket Cap Chart
Since September 26, 2024, FullHope Biomedical's market cap has decreased from 2.19B to 1.07B, a decrease of -51.28%. That is a compound annual growth rate of -32.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 1.07B | -12.72% |
| Dec 31, 2025 | 1.22B | -21.71% |
| Dec 31, 2024 | 1.56B | -28.69% |
| Sep 26, 2024 | 2.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 29.25B |
| HanchorBio | 19.60B |
| Elixiron Immunotherapeutics (Cayman) Limited | 10.97B |
| Intelligene | 6.96B |
| Uwell Biopharma | 6.19B |
| Tripartite Therapeutics | 5.52B |
| Obigen Pharma | 3.85B |
| Pet Pharm Biotech | 2.71B |